ArticleBlood and lymphatic cancer : targets and therapy2026
Efficacy and Safety of an Orelabrutinib-Based Oral Induction Regimen in Central Nervous System Lymphoma: A Real-World Study.
Yawen Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.